BMC Medical Co. Ltd. A - Asset Resilience Ratio
BMC Medical Co. Ltd. A (301367) has an Asset Resilience Ratio of 55.90% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read BMC Medical Co. Ltd. A total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2020–2024)
This chart shows how BMC Medical Co. Ltd. A's Asset Resilience Ratio has changed over time. See BMC Medical Co. Ltd. A book value and equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down BMC Medical Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is BMC Medical Co. Ltd. A worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥1.97 Billion | 55.9% |
| Total Liquid Assets | CN¥1.97 Billion | 55.90% |
Asset Resilience Insights
- Very High Liquidity: BMC Medical Co. Ltd. A maintains exceptional liquid asset reserves at 55.90% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
BMC Medical Co. Ltd. A Industry Peers by Asset Resilience Ratio
Compare BMC Medical Co. Ltd. A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087 |
Medical Instruments & Supplies | 9.08% |
|
Vizionfocus Inc.
TW:4771 |
Medical Instruments & Supplies | 5.07% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 4.42% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 51.82% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 6.36% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
|
Trajan Group Holdings Ltd
AU:TRJ |
Medical Instruments & Supplies | 0.23% |
|
Osteopore Ltd
AU:OSX |
Medical Instruments & Supplies | 43.09% |
Annual Asset Resilience Ratio for BMC Medical Co. Ltd. A (2020–2024)
The table below shows the annual Asset Resilience Ratio data for BMC Medical Co. Ltd. A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 66.74% | CN¥2.29 Billion ≈ $334.47 Million |
CN¥3.42 Billion ≈ $501.16 Million |
+4.64pp |
| 2023-12-31 | 62.10% | CN¥1.81 Billion ≈ $265.22 Million |
CN¥2.92 Billion ≈ $427.07 Million |
-11.70pp |
| 2022-12-31 | 73.80% | CN¥2.16 Billion ≈ $316.08 Million |
CN¥2.93 Billion ≈ $428.28 Million |
+26.50pp |
| 2021-12-31 | 47.30% | CN¥295.00 Million ≈ $43.17 Million |
CN¥623.69 Million ≈ $91.27 Million |
+20.78pp |
| 2020-12-31 | 26.52% | CN¥124.00 Million ≈ $18.15 Million |
CN¥467.64 Million ≈ $68.43 Million |
-- |
About BMC Medical Co. Ltd. A
BMC Medical Co., Ltd. researches, develops, manufactures, and supplies medical equipment and consumable in the field of respiratory health in China. It offers sleep-disordered breathing (SDB) diagnostic devices, non-invasive ventilators, high-flow nasal cannula oxygen therapy devices, oxygen concentrator, and respiratory consumables, such as various types of masks, breathing tubes, etc., as well … Read more